Skip to content
DraconiticResearch
Search Sources API
226,742 studies31 sourcesUpdated 40 min ago
Peer-reviewedCC BY 4.0Journal of Clinical Medicine

Clinical Response to Regenerative Therapies for Erectile Dysfunction: A Systematic Review and Meta-Analysis of Responder Outcomes

  1. 1Department of Urology, JSC “National Scientific Medical Center”, Astana 010000, Kazakhstan
  2. 2Center of Stem Cell Technology and Transplantation, JSC “National Scientific Medical Center”, Astana 010000, Kazakhstan
  3. 3Medi-Art Clinic, Astana 010000, Kazakhstan

Abstract

Background/Objectives: Regenerative therapies are increasingly used for organic erectile dysfunction (ED), but their effects on erectile function and clinically meaningful response remain uncertain. We evaluated erectile-function scores, penile hemodynamics, and responder outcomes. Methods: We searched PubMed, Scopus, and Cochrane CENTRAL from January 1999 to June 2026. Controlled, active-comparator, and uncontrolled studies were analysed separately. Random-effects models synthesised continuous and responder outcomes by follow-up period. We assessed risk of bias using RoB 2 and ROBINS-I and rated certainty of evidence using GRADE. Results: We included 46 study reports comprising 18 randomized trials and 28 non-randomized studies. In controlled comparisons, mean International Index of Erectile Function (IIEF) scores favored treatment at short-term follow-up (≤12 weeks; Hedges’ g = 1.08, 95% CI 0.64–1.52). The mid-term estimate was less precise (13–24 weeks; g = 0.49, 95% CI −0.02 to 1.01). Controlled Erection Hardness Score estimates were also imprecise. Risk ratios for study-defined clinically meaningful improvement in the IIEF erectile function domain were 2.51 (95% CI 0.76–8.31), 2.62 (0.56–12.36), and 2.67 (0.58–12.22) at 4, 12, and 24 weeks, respectively. Exploratory within-group analyses showed post-treatment changes in erectile function and peak systolic velocity, with substantial heterogeneity across several analyses. Conclusions: Controlled studies favored regenerative therapies for short-term improvement in mean erectile-function scores. Whether more patients achieve a clinically meaningful response, how long any benefit lasts, and which therapies are most effective remain uncertain. The review was registered with PROSPERO (CRD420261421415).

Related

  1. Completeness and guideline concordance of artificial intelligence chatbot responses to patient questions on regenerative therapies for erectile dysfunction: a multi-platform analysis.
    Ethan L Low, Jamie Welsh, Evan Burchfiel +5
    Translational andrology and urologyPeer-reviewedCC BY-NC-NDFull textEpidemiology & public healthEurope PMCPMC
  2. Smart Alerting in Smartphone‐Based First Responder Systems and Arrival Before Emergency Medical Services:The ALARM Randomized Clinical Trial
    Julian Ganter, Julian Gronewald, Axel Rüdiger Heller +5
    Journal of the American Heart AssociationPeer-reviewedLicence not statedCardiovascular medicineCrossref
  3. Intranasal delivery of regenerative biologics for neurological disorders: a systematic review of clinical studies
    Umm E Habiba, Iqra Sarwar, Sabiha Shamim +1
    Frontiers in drug deliveryPeer-reviewedCC BYFull textPharmacology & toxicologyEurope PMCPMC
  4. Efficacy of nutraceuticals as adjunctive therapies in autoimmune diseases: A systematic review of clinical trials.
    Jennifer Carolina Flores Iglesias, Luis Fernando Méndez López
    BioImpacts : BIPeer-reviewedCC BY-NCFull textGeneral medicineEurope PMC
  5. Precision targeting and regenerative therapies in articular cartilage diseases with AI-driven theranostics
    Yue Pan, Yanbo Peng, Jinxia Han +7
    Journal of NanobiotechnologyPeer-reviewedCC BY-NC-ND 4.0Full text1 citedGeneral medicinePMC
BibTeX
@article{omarbayev2026clinical,
  title = {{Clinical Response to Regenerative Therapies for Erectile Dysfunction: A Systematic Review and Meta-Analysis of Responder Outcomes}},
  author = {Rustam Omarbayev and Yerbol Iskakov and Aliya Orassay and Rinat Nugumanov and Saule Paizullayeva and Manarbek Askarov},
  journal = {Journal of Clinical Medicine},
  year = {2026},
  month = nov,
  doi = {10.3390/jcm15228895},
  url = {https://www.mdpi.com/2077-0383/15/22/8895},
  note = {CC BY 4.0},
}
RIS
TY  - JOUR
TI  - Clinical Response to Regenerative Therapies for Erectile Dysfunction: A Systematic Review and Meta-Analysis of Responder Outcomes
AU  - Rustam Omarbayev
AU  - Yerbol Iskakov
AU  - Aliya Orassay
AU  - Rinat Nugumanov
AU  - Saule Paizullayeva
AU  - Manarbek Askarov
PY  - 2026
DA  - 2026/11/13
JO  - Journal of Clinical Medicine
DO  - 10.3390/jcm15228895
UR  - https://www.mdpi.com/2077-0383/15/22/8895
AB  - Background/Objectives: Regenerative therapies are increasingly used for organic erectile dysfunction (ED), but their effects on erectile function and clinically meaningful response remain uncertain. We evaluated erectile-function scores, penile hemodynamics, and responder outcomes. Methods: We searched PubMed, Scopus, and Cochrane CENTRAL from January 1999 to June 2026. Controlled, active-comparator, and uncontrolled studies were analysed separately. Random-effects models synthesised continuous and responder outcomes by follow-up period. We assessed risk of bias using RoB 2 and ROBINS-I and rated certainty of evidence using GRADE. Results: We included 46 study reports comprising 18 randomized trials and 28 non-randomized studies. In controlled comparisons, mean International Index of Erectile Function (IIEF) scores favored treatment at short-term follow-up (≤12 weeks; Hedges’ g = 1.08, 95% CI 0.64–1.52). The mid-term estimate was less precise (13–24 weeks; g = 0.49, 95% CI −0.02 to 1.01). Controlled Erection Hardness Score estimates were also imprecise. Risk ratios for study-defined clinically meaningful improvement in the IIEF erectile function domain were 2.51 (95% CI 0.76–8.31), 2.62 (0.56–12.36), and 2.67 (0.58–12.22) at 4, 12, and 24 weeks, respectively. Exploratory within-group analyses showed post-treatment changes in erectile function and peak systolic velocity, with substantial heterogeneity across several analyses. Conclusions: Controlled studies favored regenerative therapies for short-term improvement in mean erectile-function scores. Whether more patients achieve a clinically meaningful response, how long any benefit lasts, and which therapies are most effective remain uncertain. The review was registered with PROSPERO (CRD420261421415).
SN  - 2077-0383
ER  -